Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals

Preparation of molecular probes targeting urokinase plasminogen activator (uPA) for imaging aggressive and metastatic tumors

Karin Stephenson, Jennifer Lemon, Neva Lazarova and John Valliant
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 442;
Karin Stephenson
1Centre for Probe Development and Commercialization, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Lemon
2McMaster University, McMaster Institute of Applied Radiation Sciences, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neva Lazarova
1Centre for Probe Development and Commercialization, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Valliant
3McMaster University, Dept. of Chemistry, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 50 no. supplement 2 442

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 3, 2014.

Copyright & Usage 
© 2009 by Society of Nuclear Medicine

Author Information

  1. Karin Stephenson1,
  2. Jennifer Lemon2,
  3. Neva Lazarova1 and
  4. John Valliant3
  1. 1Centre for Probe Development and Commercialization, Hamilton, ON, Canada
  2. 2McMaster University, McMaster Institute of Applied Radiation Sciences, Hamilton, ON, Canada
  3. 3McMaster University, Dept. of Chemistry, Hamilton, ON, Canada

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: July 2015 to April 2025

AbstractFullPdf
Jul 2015100
Sep 2015400
May 2016100
Oct 2016200
Nov 2016200
Dec 2016100
Jan 2017400
Feb 2017200
Mar 2017400
Apr 2017200
May 2017300
Jun 2017100
Jul 2017300
Aug 2017200
Sep 2017200
Oct 2017300
Jun 2018100
Jul 2018100
Sep 2018300
Oct 2018100
Dec 2018300
Feb 2019100
Apr 2019100
Feb 2020400
Mar 20201400
Apr 2020800
Jun 2020100
Jul 2020400
Aug 20202600
Sep 20204100
Oct 20201200
Nov 20201500
Dec 2020800
Jan 2021200
Feb 2021800
Mar 2021600
Apr 2021700
May 20211700
Jun 20211800
Jul 20215700
Aug 20215300
Sep 2021900
Oct 20214600
Nov 20215200
Dec 20213500
Jan 20226000
Feb 20221600
Mar 20221700
Apr 2022600
May 20222200
Jun 2022100
Aug 2022200
Oct 2022300
Nov 2022100
Mar 2023400
Apr 2023100
May 2023200
Jun 2023100
Jul 2023100
Aug 2023200
Sep 2023200
Oct 2023600
Nov 2023100
Dec 2023200
Jan 2024500
Mar 2024200
Apr 2024100
May 2024600
Jun 2024100
Jul 2024100
Aug 2024400
Sep 2024500
Oct 2024200
Nov 2024500
Dec 2024200
Mar 2025100
Apr 2025500
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preparation of molecular probes targeting urokinase plasminogen activator (uPA) for imaging aggressive and metastatic tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preparation of molecular probes targeting urokinase plasminogen activator (uPA) for imaging aggressive and metastatic tumors
Karin Stephenson, Jennifer Lemon, Neva Lazarova, John Valliant
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 442;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preparation of molecular probes targeting urokinase plasminogen activator (uPA) for imaging aggressive and metastatic tumors
Karin Stephenson, Jennifer Lemon, Neva Lazarova, John Valliant
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 442;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals

  • Pre-clinical evaluation of 124I-FIAU and 18F-FIAU for the assessment of the HSV1-tk reporter gene expression with PET
  • Preparation of a novel bifunctional chelator AmBaSar based on sarcophagine for Cu-64 radiopharmaceuticals
  • Development of 68Ga-lactosylated human serum albumin (LSA) for imaging the hepatic asialoglycoprotein receptor
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals

Novel Probe Development IV

  • A novel RGD-conjugated alpha-MSH hybrid peptide for melanoma therapy
  • Synthesis of novel 4-iodophenyl sphingosine derivatives as potential tumor imaging agents
Show more Novel Probe Development IV

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire